Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer

Tara Hyder,1 Saveri Bhattacharya,2,* Kristine Gade,3,* Azadeh Nasrazadani,3 Adam M Brufsky3 1University of Pittsburgh Physicians, Pittsburgh, PA, USA; 2Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA; 3UPMC Hillman Cancer Center, Magee...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hyder T, Bhattacharya S, Gade K, Nasrazadani A, Brufsky AM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
pcr
Acceso en línea:https://doaj.org/article/5f635ff8701c42129f91df04a69b4463
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5f635ff8701c42129f91df04a69b4463
record_format dspace
spelling oai:doaj.org-article:5f635ff8701c42129f91df04a69b44632021-12-02T15:59:22ZApproaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer1179-1314https://doaj.org/article/5f635ff8701c42129f91df04a69b44632021-03-01T00:00:00Zhttps://www.dovepress.com/approaching-neoadjuvant-therapy-in-the-management-of-early-stage-breas-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Tara Hyder,1 Saveri Bhattacharya,2,* Kristine Gade,3,* Azadeh Nasrazadani,3 Adam M Brufsky3 1University of Pittsburgh Physicians, Pittsburgh, PA, USA; 2Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA; 3UPMC Hillman Cancer Center, Magee Women’s Hospital, Pittsburgh, PA, USA*These authors contributed equally to this workCorrespondence: Adam M BrufskyUPMC Hillman Cancer Center, Magee Women’s Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA, 15213, USAEmail brufskyam@upmc.eduAbstract: Neoadjuvant therapy is integral to the treatment of early-stage breast cancer. Goals of treatment include surgical downstaging of the tumor, rendering inoperable tumors resectable, and de-escalating axillary surgery in those with clinically positive nodes. Additionally, response to treatment provides important prognostic information regarding risk of recurrence and guides future adjuvant treatment. Although chemotherapy serves as the backbone of neoadjuvant treatment, an increased understanding of the tumor’s clinical course as well as its molecular and genetic make-up aids in individualizing treatment and developing novel agents. This review summarizes current clinical approaches and the future direction to the management of breast cancer patients in the neoadjuvant setting.Keywords: neoadjuvant chemotherapy, neoadjuvant endocrine therapy, pCR, breast-conserving surgeryHyder TBhattacharya SGade KNasrazadani ABrufsky AMDove Medical Pressarticleneoadjuvant chemotherapyneoadjuvant endocrine therapypcrbreast conserving surgeryNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol Volume 13, Pp 199-211 (2021)
institution DOAJ
collection DOAJ
language EN
topic neoadjuvant chemotherapy
neoadjuvant endocrine therapy
pcr
breast conserving surgery
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle neoadjuvant chemotherapy
neoadjuvant endocrine therapy
pcr
breast conserving surgery
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Hyder T
Bhattacharya S
Gade K
Nasrazadani A
Brufsky AM
Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
description Tara Hyder,1 Saveri Bhattacharya,2,* Kristine Gade,3,* Azadeh Nasrazadani,3 Adam M Brufsky3 1University of Pittsburgh Physicians, Pittsburgh, PA, USA; 2Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA; 3UPMC Hillman Cancer Center, Magee Women’s Hospital, Pittsburgh, PA, USA*These authors contributed equally to this workCorrespondence: Adam M BrufskyUPMC Hillman Cancer Center, Magee Women’s Hospital, Suite 4628, 300 Halket Street, Pittsburgh, PA, 15213, USAEmail brufskyam@upmc.eduAbstract: Neoadjuvant therapy is integral to the treatment of early-stage breast cancer. Goals of treatment include surgical downstaging of the tumor, rendering inoperable tumors resectable, and de-escalating axillary surgery in those with clinically positive nodes. Additionally, response to treatment provides important prognostic information regarding risk of recurrence and guides future adjuvant treatment. Although chemotherapy serves as the backbone of neoadjuvant treatment, an increased understanding of the tumor’s clinical course as well as its molecular and genetic make-up aids in individualizing treatment and developing novel agents. This review summarizes current clinical approaches and the future direction to the management of breast cancer patients in the neoadjuvant setting.Keywords: neoadjuvant chemotherapy, neoadjuvant endocrine therapy, pCR, breast-conserving surgery
format article
author Hyder T
Bhattacharya S
Gade K
Nasrazadani A
Brufsky AM
author_facet Hyder T
Bhattacharya S
Gade K
Nasrazadani A
Brufsky AM
author_sort Hyder T
title Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
title_short Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
title_full Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
title_fullStr Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
title_full_unstemmed Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
title_sort approaching neoadjuvant therapy in the management of early-stage breast cancer
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/5f635ff8701c42129f91df04a69b4463
work_keys_str_mv AT hydert approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer
AT bhattacharyas approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer
AT gadek approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer
AT nasrazadania approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer
AT brufskyam approachingneoadjuvanttherapyinthemanagementofearlystagebreastcancer
_version_ 1718385331491831808